The primary application of these catheters lies in renal replacement therapy. These catheters are used to establish temporary vascular access for individuals with end-stage renal disease (ESRD) or acute kidney injury (AKI) who require regular hemodialysis. They provide a conduit for the efficient removal and return of blood during the dialysis process. In emergency medicine, these catheters are pivotal in rapidly establishing vascular access for urgent dialysis procedures.
Ongoing advancements in materials, design, and technology are shaping the landscape of these catheters. Manufacturers invest in research and development to introduce catheters with improved biocompatibility, reduced thrombogenicity, and innovative features such as antimicrobial coatings. These advancements aim to improve the safety and effectiveness of hemodialysis procedures. There is a noticeable trend towards the use of tunneled catheters. Unlike non-tunneled catheters, tunneled catheters are inserted with a portion of the catheter tunneled under the skin. This design reduces the risk of infections and provides more stable vascular access, making them preferable for long-term hemodialysis.
Diabetes and hypertension, two main risk factors for kidney disorders, including acute kidney injury (AKI), are highly prevalent in Saudi Arabia. The occurrence of infectious diseases in Saudi Arabia contributes to a higher incidence of AKI, particularly in cases of severe or untreated infections. The presence of chronic diseases beyond diabetes and hypertension, such as cardiovascular diseases and autoimmune conditions, contributes to the development of AKI in Saudi Arabia. Hence, due to these aspects, the market will expand across the LAMEA region in upcoming years.
The Brazil market dominated the LAMEA Hemodialysis Catheters Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $25.8 Million by 2030. The Argentina market is showcasing a CAGR of 6.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 5.8% during (2023 - 2030).
Based on Material, the market is segmented into Polyurethane, and Silicone. Based on Product, the market is segmented into Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled. Based on Tip Configuration, the market is segmented into Step-Tip Catheters, Split-Tip Catheters, and Symmetric Catheters. Based on End User, the market is segmented into Hospitals, Clinics/Dialysis Centers, and Home Dialysis. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Teleflex Incorporated
- Medtronic Plc
- AngioDynamics, Inc.
- Bayer Ag
- B.Braun Melsungen AG
- Baxter International, Inc
- NIPRO Corporation
- Covalon Technologies Ltd.
- Fresenius Medical Care AG & Co. KGaA
- DaVita Inc.
Market Report Segmentation
By Material (Volume, Thousand Units, USD Billion, 2019-2030)- Polyurethane
- Silicone
- Cuffed Tunneled
- Non-Cuffed Tunneled
- Non-Tunneled
- Step-Tip Catheters
- Split-Tip Catheters
- Symmetric Catheters
- Hospitals
- Clinics/Dialysis Centers
- Home Dialysis
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Companies Mentioned
- Teleflex Incorporated
- Medtronic Plc
- AngioDynamics, Inc.
- Bayer Ag
- B. Braun Melsungen AG
- Baxter International, Inc
- NIPRO Corporation
- Covalon Technologies Ltd.
- Fresenius Medical Care AG & Co. KGaA
- DaVita Inc.
Methodology
LOADING...